blackbird Posted December 12, 2006 Share Posted December 12, 2006 I receive the HealthyPlace thought disorders newsletter every week and this weeks issue states that older drugs are just as effective as the second generation atypicals at treating schizophrenia, it particularly praises Fluphenazine (excuse me if I spelt that wrong) Older drugs Must be why I love Haldol so much! Link to comment Share on other sites More sharing options...
resonance Posted December 12, 2006 Share Posted December 12, 2006 It's weird that for so long people have been saying atypicals are better than the typicals, and then newer studies come out saying they aren't. I wonder what changed. Drug company-fueled early studies? Chance kicking you in the ass when it came to random assignment? Who knows? Link to comment Share on other sites More sharing options...
Dweii Posted December 12, 2006 Share Posted December 12, 2006 I would say it's possible. I've been on Haldol and Fluanxol and I'm always trying to convince people they are not as scary as many believe. Link to comment Share on other sites More sharing options...
blackbird Posted December 12, 2006 Author Share Posted December 12, 2006 I'm quite interested in trying Stelazine if the binge eating and bulimia induced by Zyprexa becomes intolerable. Anyone any experience with Stelazine? Link to comment Share on other sites More sharing options...
Loon-A-TiK Posted December 12, 2006 Share Posted December 12, 2006 no i haven't blackbird. NAMI's position on atypicals vs. old school antipsychotics is that people need to have a choice in determining the best med for them, and different agencies (including the gov) may use these findings to eliminate funding for atypicals. atypicals usually have a lower side effect profile and a lower risk of TD. Link to comment Share on other sites More sharing options...
Velvet Elvis Posted December 13, 2006 Share Posted December 13, 2006 It's a matter of how you define effective. If it's just reversal of symptoms, I don't think there has ever been any debate that the atypicals don't have much of an advantage. It's the lack of side effects, the TD risk particular that's that's important. If this is the same study I heard about on NPR recently it's well intentioned but misguided. Um. More in a bit. I wanna look somthing up. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.